NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,679,301 | +740.3% | 80,037 | +670.8% | 0.02% | +950.0% |
Q2 2023 | $437,851 | +56.5% | 10,383 | -3.2% | 0.00% | +100.0% |
Q1 2023 | $279,789 | -20.3% | 10,724 | -9.0% | 0.00% | -50.0% |
Q4 2022 | $351,047 | -12.5% | 11,788 | -42.9% | 0.00% | 0.0% |
Q3 2022 | $401,000 | +371.8% | 20,651 | +230.5% | 0.00% | – |
Q2 2022 | $85,000 | – | 6,249 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |